Improvement in Left Ventricular Diastolic Stiffness Induced by Physical Training in Patients with Dilated Cardiomyopathy
Overview
Authors
Affiliations
Background: Diastolic dysfunction in long-term heart failure is accompanied by abnormal neurohormonal control and ventricular stiffness. The diastolic phase is determined by a balance between pressure gradients and intrinsic ventricular wall properties: according to a mathematical model, the latter (ie, left ventricular [LV] elastance, K(LV)) may be calculated by the formula: K(LV) = (70/[DT-20])(2) mm Hg/mL, where DT is the transmitral Doppler deceleration time.
Methods And Results: In 54 patients with chronic systolic heart failure (39 men, 15 women; age 65 +/- 10 years; New York Heart Association [NYHA], 2.3 +/- 0.9; ejection fraction [EF], 32% +/- 5%), we analyzed the relationship between K(LV) and an index of neurohormonal derangement (levels of brain natriuretic peptide [BNP]), and investigated whether 3 months of physical training could modulate diastolic operating stiffness. Patients were randomized to physical training (n = 27) or to a control group (n = 27). Before and after training, patients underwent Doppler echocardiogram and cardiopulmonary stress test. At baseline, ventricular stiffness was related to BNP levels (P < .01). Training improved NYHA class, exercise performance, and estimated pulmonary pressure. BNP was reduced. Ventricular volumes, mean blood pressure, and EF remained unchanged. A 27% reduction of elastance was observed (K(LV), 0.111 +/- 0.044 from 0.195 +/- 0.089 mm Hg/mL; P < .01), whose magnitude was related to changes in BNP (P < .05) and to K(LV) at baseline (P < .01). No changes in K(LV) were observed in controls after 3 months (0.192 +/- 0.115 from 0.195 +/- 0.121 mm Hg/mL).
Conclusions: In heart failure, left ventricular diastolic stiffness is related to neurohormonal derangement and is modified by physical training. This improvement in LV compliance could result from a combination of hemodynamic improvement and regression of the fibrotic process.
Baccanelli G, Tomaselli M, Ferri U, Giglio A, Munforti C, Parati G Int J Cardiol Cardiovasc Risk Prev. 2023; 17:200178.
PMID: 36895839 PMC: 9988546. DOI: 10.1016/j.ijcrp.2023.200178.
Chaveles I, Papazachou O, Shamari M, Delis D, Ntalianis A, Panagopoulou N World J Cardiol. 2021; 13(9):514-525.
PMID: 34621496 PMC: 8462045. DOI: 10.4330/wjc.v13.i9.514.
Alphonsus C, Govender P, Rodseth R, Biccard B Perioper Med (Lond). 2019; 8:14.
PMID: 31832178 PMC: 6859626. DOI: 10.1186/s13741-019-0124-0.
Tucker W, Beaudry R, Liang Y, Clark A, Tomczak C, Nelson M Prog Cardiovasc Dis. 2018; 62(2):163-171.
PMID: 30227187 PMC: 6445773. DOI: 10.1016/j.pcad.2018.08.006.
Pearson M, King N, Smart N Open Heart. 2018; 5(2):e000819.
PMID: 30018779 PMC: 6045761. DOI: 10.1136/openhrt-2018-000819.